Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boyd

Showing results (331-340 of 476) with videos related to

Pageof 48
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1995
Plasma lipids, lipoproteins, and familial breast cancerN F Boyd, P Connelly, H Lynch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160M Shirai, K Kurokohchi, C D Pendleton, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1973
Mechanism of action of nerve growth factor and cyclic AMP on neurite outgrowth in embryonic chick sensory ganglia: demonstration of independent pathways of stimulationW A Frazier, C E Ohlendorf, L F Boyd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2020
Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor ImmunityAbir K Panda, Arunakumar Gangaplara, Maja Buszko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancerNorman F Boyd, Lisa J Martin, Qing Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibodyD H Chung, I M Belyakov, M A Derby, et al.
Archives of Internal Medicine|October 1, 1985
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled studyL A Manchul, A Jin, K I Pritchard, et al.
Investigational New Drugs|February 1, 1991
Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group studyD D Von Hoff, S J Green, J A Neidhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancerI F Tannock, N F Boyd, G DeBoer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasionRui Wang, Kannan Natarajan, Maria Jamela R Revilleza, et al.
Pageof 48

Showing results (331-340 of 476) with videos related to

Sort By:
Pageof 48
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1995
Plasma lipids, lipoproteins, and familial breast cancerN F Boyd, P Connelly, H Lynch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160M Shirai, K Kurokohchi, C D Pendleton, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1973
Mechanism of action of nerve growth factor and cyclic AMP on neurite outgrowth in embryonic chick sensory ganglia: demonstration of independent pathways of stimulationW A Frazier, C E Ohlendorf, L F Boyd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2020
Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor ImmunityAbir K Panda, Arunakumar Gangaplara, Maja Buszko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancerNorman F Boyd, Lisa J Martin, Qing Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibodyD H Chung, I M Belyakov, M A Derby, et al.
Archives of Internal Medicine|October 1, 1985
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled studyL A Manchul, A Jin, K I Pritchard, et al.
Investigational New Drugs|February 1, 1991
Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group studyD D Von Hoff, S J Green, J A Neidhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancerI F Tannock, N F Boyd, G DeBoer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasionRui Wang, Kannan Natarajan, Maria Jamela R Revilleza, et al.
Pageof 48